Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Bibliographic Details
Main Authors:	Hassan Awada, Mina Abdelmalek, Tara Cronin, Jeffrey Baron, Zakariya Kashour, Farhan Azad, Muhammad Salman Faisal, Mark Faber, Matthew Gravina, Pamela J. Sung, Steven D. Green, Amanda Przespolewski, James E. Thompson, Elizabeth A. Griffiths, Eunice S. Wang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-09-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-023-00910-x

Internet